Evidence map›Paper›PMID 32708220›Full record

ArticleInternational journal of molecular sciences2020

The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors.

Ugne Gyvyte, Rokas Lukosevicius, Ruta Inciuraite, Greta Streleckiene, Greta Gudoityte, Justina Bekampyte, Serena Valentini, Violeta Salteniene, Paulius Ruzgys, Saulius Satkauskas and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Effects of total coumarins fromPharmaceutical biology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ugne GyvyteInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Rokas LukoseviciusInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Ruta InciuraiteInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Greta StreleckieneInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Greta GudoityteInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0000-0002-9419-1850
Justina BekampyteInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0000-0002-2066-8193
Serena ValentiniDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, IT-40126 Bologna, Italy.
Violeta SaltenieneInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Paulius RuzgysBiophysical Research Group, Faculty of Natural Sciences, Vytautas Magnus University, LT-44404 Kaunas, Lithuania.ORCID 0000-0002-4501-4073
Saulius SatkauskasBiophysical Research Group, Faculty of Natural Sciences, Vytautas Magnus University, LT-44404 Kaunas, Lithuania.ORCID 0000-0002-9001-7767
Kristina ZvinieneDepartment of Radiology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Juozas KupcinskasInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0000-0002-8760-7416
Jurgita SkiecevicieneInstitute for Digestive Research, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTVytautas Magnus University · LTUniversity of Bologna · IT

Funding

Research Council of Lithuania MIP-006/2014
6 · The paper itself

Abstract

Deregulated microRNA (miRNA) expression profiles and their contribution to carcinogenesis have been observed in virtually all types of human cancer. However, their role in the pathogenesis of rare mesenchymal gastrointestinal stromal tumors (GISTs) is not well defined, yet. In this study, we aimed to investigate the role of two miRNAs strongly downregulated in GIST-miR-375-3p and miR-200b-3p-in the pathogenesis of GIST. To achieve this, miRNA mimics were transfected into GIST-T1 cells and changes in the potential target gene mRNA and protein expression, as well as alterations in cell viability, migration, apoptotic cell counts and direct miRNA-target interaction, were evaluated. Results revealed that overexpression of miR-375-3p downregulated the expression of KIT mRNA and protein by direct binding to KIT 3'UTR, reduced GIST cell viability and migration rates. MiR-200b-3p lowered expression of ETV1 protein, directly targeted and lowered expression of EGFR mRNA and protein, and negatively affected cell migration rates. To conclude, the present study identified that miR-375-3p and miR-200b-3p have a tumor-suppressive role in GIST.

Indexed as

3' Untranslated RegionsApoptosisCell Line, TumorCell MovementCell ProliferationCell SurvivalDNA-Binding ProteinsDown-RegulationErbB ReceptorsGastrointestinal NeoplasmsGastrointestinal Stromal TumorsGene Expression Regulation, NeoplasticHumansMicroRNAsTranscription Factors3' Untranslated RegionsDNA-Binding ProteinsEGFR protein, humanErbB ReceptorsETV1 protein, humanMicroRNAsMIRN200 microRNA, humanMIRN375 microRNA, humanTranscription Factorsgastrointestinal stromal tumorGISTmiR-200b-3pmiR-375-3pmiRNA

Identifiers

PMID32708220
PMCPMC7404198
OpenAlexW3045417197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.